2 Tiger Global Abiomed Trades
Tiger Global started to build up the position in Abiomed in Q2 2014. Since then they sold 1.69 Million shares. The investor sold all their shares in Q4 2014 and doesn't own any shares in Abiomed anymore.
News about Abiomed Inc. and Tiger Global
Artificial Heart Market Share, Size and Demand Report 2022 : Increase in Number of People Suffering from Cardiovascular Diseases : Abbott, AbioMed, MyLVAD
The Global Artificial Heart Market Size is projected to reach USD 54.28 million by 2028, exhibiting a CAGR of 16.16% during the forecast period. London, UK -...
Is Abiomed (ABMD) A Great Investment to Take?
Harding Loevner, an investment management firm, published its “Global Small Companies Equity Fund” fourth quarter 2021 investor letter – a copy of which can ...
Cardiac Assist Devices Market 2021 Global Analysis by Key Players Terumo Corporation, BERLIN HEART GmbH, MAQUET GmbH, Teleflex Incorporated, ABIOMED Inc, Abbott Laboratories, Medtronic PLC, CARMAT SA
Cardiac Assist Devices or CADs are the heart pumping devices that work along-side heart and are used to stabilize the pumping ability and proper maintenance ...
New Study from StrategyR Highlights a $80.1 Million Global Market for Tipper Trucks by 2026
SAN FRANCISCO , Sept. 15, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, toda...